Dr Leigh Madden
| Biography | Leigh came to the University of Hull to study Applied Biology in 1991. He specialised in biotechnology in the final year of his degree and then proceeded to continue into a research career starting with PhD and postdoctoral positions fully funded through industry (Monsanto Inc, USA). Following this he switched fields into medical research in 2000 and has been at Hull ever since. Leigh is an author on over 100 peer-reviewed papers which have been cited over 4000 times (h-index 36), covering a wide range of interests and has worked closely with clinical leads, colleagues in HYMS, Chemistry and Sport Health and Exercise Science as well as commercial partners from City Healthcare Partnership, North of England Medical Hyperbaric Services, Mimir Marine and QinetiQ. Leigh has helped supervise many students across a wide range of research fields including cancer associated coagulation, diabetes, polycystic ovary syndrome, bioimprinting, tissue engineering, decompression sickness, exercise in clinical populations to clinical trials of investigative medicinal products (CTIMPs) and App development. |
|---|---|
| Research Interests | Leigh’s main research interest lies within the field of extracellular vesicles in which he has been actively conducting and publishing research since 2003 when he was part of the first ever study investigating the role of extracellular vesicles in decompression sickness. Always keen to contribute to new research Leigh has collaborated across a wide spectrum of projects within the medical field. |
| Scopus Author ID | 7006980620 |
| PhD Supervision Availability | Yes |
| PhD Topics | Extracellular vesicles – clinical and/or laboratory based Cancer associated hypercoagulability – clinical and/or laboratory based Bioimprinting – laboratory based Tissue engineering – laboratory based Diabetes, Obesity and Polycystic ovary syndrome – clinical and/or laboratory based |